Skip to content
GERICLINICS

GeriQBank · Paper III · Q8

Osteoarthritis — Management

Moderate YieldAsked ×16-mark note
Chapter
Metabolic Bone Disease & Rheumatology
Years asked
Not recorded in the source
Frequency
Set 1× in Paper III (2009–2025)

As set in the university paper

  • Osteoarthritis management.

    Paper III · Bone, Joint & Rheumatology · asked ×1 · 6-mark note · see in paper list

Detailed answer

Pro · free in beta
Attempt it firstOutline your answer as a 6-mark note before revealing it — definition, causes, evaluation, management and the geriatric angle.Reveal answer

A. Principles

1.

Osteoarthritis is the commonest joint disease of older adults and a leading cause of pain, immobility and disability. Management is symptom-directed and function-directed, since no agent has been shown to reverse structural damage.

2.

Optimal management involves multiple treatment modalities, and the best combination varies from patient to patient (Kane's) — a core, quotable line.

3.

Treating arthritis optimally requires a differential diagnosis, because several arthritides coexist in older adults. Distinguish OA from inflammatory arthritis: stiffness lasting minutes not hours, pain with activity rather than at rest and at night, fatigue unusual, swelling present but with little synovial reaction, and erythema and warmth unusual.

B. Non-Pharmacological Management (the foundation)

4.

Education and self-management, with realistic goal-setting and an explanation that OA is manageable rather than inevitable disability.

5.

Exercise is first-line: quadriceps and hip abductor strengthening, range-of-movement work, and low-impact aerobic activity. Patients referred for joint replacement should be encouraged to lose weight and strengthen the relevant muscles before surgery.

6.

Weight reduction — the single most effective disease-modifying intervention for knee and hip OA.

7.

Physiotherapy and occupational therapy: joint protection, energy conservation, activity pacing, and assessment for assistive devices — walking stick held in the contralateral hand, walking frame, raised toilet seat, tap turners, jar openers.

8.

Orthoses and footwear: shock-absorbing insoles, appropriate footwear, knee braces for varus/valgus instability, thumb-base splint for first carpometacarpal OA.

9.

Local physical measures: heat, cold, and transcutaneous electrical nerve stimulation as adjuncts.

C. Pharmacological Management

10.

Paracetamol is the traditional first-line oral analgesic in older people because of its favourable safety profile, though its efficacy in OA is modest; maximum 3 g/day in the frail elderly.

11.

Topical NSAIDs are preferred over oral NSAIDs for knee and hand OA in older adults, giving useful analgesia with minimal systemic exposure. Topical capsaicin is an alternative.

12.

Oral NSAIDs — lowest dose, shortest duration, always with a proton-pump inhibitor. Hazardous in the elderly: gastrointestinal bleeding, acute kidney injury, fluid retention and heart failure decompensation, hypertension, and interaction with ACE inhibitors and diuretics ("triple whammy"). They appear on the AGS Beers Criteria as potentially inappropriate for chronic use.

13.

Intra-articular corticosteroid injection for a painful effusive flare gives short-term relief; limit to three or four injections per joint per year. Local steroid injection also gives dramatic relief in bicipital tendinitis, olecranon and trochanteric bursitis, which are common in geriatric patients and must be sought on examination.

14.

Nutraceuticals: glucosamine and chondroitin — although there may be a placebo effect resulting in benefit, there is no evidence of significant improvement in pain; likewise vitamin D does not decrease pain or facilitate repair of structural damage in OA.

15.

Duloxetine and, cautiously, low-dose weak opioids (tramadol) are reserved for refractory pain; opioids carry falls, delirium, constipation and dependence risk in older adults.

D. Surgical and Interventional Management

16.

Arthroscopic interventions (debridement and lavage, osteotomy, cartilage transplant) have been recommended where inflammation is present and non-invasive measures have failed, but there is little evidence to support their efficacy (Moseley et al.).

17.

Joint replacement should be reserved for individuals with severe symptomatic disease who do not respond to more conservative interventions; patients referred should have stable medical conditions and be prepared with weight loss and muscle strengthening pre-operatively.

18.

Post-operative care needs structured rehabilitation, delirium prevention, VTE prophylaxis and falls prevention.

E. Geriatric-Specific Considerations

19.

Address the consequences as much as the joint: OA causes immobility, deconditioning, sarcopenia, falls, depression, social isolation and caregiver burden — a comprehensive geriatric assessment is appropriate.

20.

Look actively for treatable non-articular mimics — tendinitis, bursitis, and carpal tunnel syndrome, which is common in older adults and can be confused with gout, rheumatoid arthritis or pseudogout.

Latest Updates (2023 – Present)

OARSI and ACR guidance continue to rank structured exercise and weight management as core, with topical NSAIDs preferred over oral NSAIDs in older adults; glucosamine, chondroitin and hyaluronic acid injections remain not recommended for knee OA.

Intra-articular corticosteroids: repeated injections have been associated with cartilage volume loss on imaging, so use is now restricted to intermittent flares rather than a routine schedule.

Community-level programmes are gaining evidence — the WE-CAN study examined the impact of a community diet-and-exercise programme on knee pain, reflecting a shift towards scalable, non-drug delivery models. Emerging pharmacology: nerve growth factor inhibitors (tanezumab) showed efficacy but rapidly progressive OA limited approval; lorecivivint (Wnt inhibitor) and low-dose colchicine are under evaluation as potential structure-modifying agents; GLP-1 receptor agonists (semaglutide, STEP-9 trial) reduce knee OA pain substantially through weight loss in obesity.

Indian context: knee OA prevalence is high, especially in women; management is supported by ADIP/ALIMCO for assistive devices and the Rashtriya Vayoshri Yojana for free aids in BPL elderly, with joint replacement covered under AB-PMJAY.

Current Practice Update

Textbook

Issue Current position position First-line analgesia Paracetamol Exercise and weight loss first; topical NSAID is the preferred first drug — paracetamol demoted to adjunct Glucosamine / chondroitin / No proven benefit Unchanged — explicitly not recommended vitamin D Arthroscopic lavage Little supporting Should not be offered for degenerative knee disease evidence Intra-articular steroid Useful for flares Same, but limit frequency — cartilage volume loss with repeated injection Weight loss Advise before Now a therapeutic target in its own right, including GLP-1 agonists in obese surgery patients Exam One-Liners OA stiffness lasts minutes; inflammatory arthritis stiffness lasts hours.

Exercise and weight loss are the only interventions that change the disease course. Walking stick goes in the hand opposite to the affected joint.

Glucosamine, chondroitin and vitamin D do not work in OA.

Arthroscopic lavage for degenerative knee disease is not supported by evidence.

Always look for bursitis, tendinitis and carpal tunnel syndrome as treatable mimics.

How was your recall?

Rating marks the question complete. “Need another pass” also adds it to your bookmarks.

References

Spotted an error or something out of date?Report a problem with this page